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RetinoidAdvanced treatment technologies are being assessed as a proactive measure to assist with the transformation of
treated wastewater into a source of water for potable water production. We investigated the biological effects
along an advanced water treatment pilot plant, using zebrafish embryos throughout early development. The study
compared phenotypic observations with global transcriptome responses, enabling us to keep an open mind about
the chemicals that might influence the biological activity. There was no evidence of acute toxicity at any treatment
stage, but skeletal, cardiovascular and pigmentation changes occurred in a small proportion of embryos along the
treatment process, and in a tap water; not detected in the aquarium water control. Reverse osmosis (RO) reduced
the concentration ofmeasured chemical contaminants in thewater themost, while eliminating the occurrence of ab-
normalities detected in fish embryos. Conversely, advanced oxidation reversed the benefits of RO treatment by in-
creasing the frequency of teratogenic and sub-lethal abnormalities seen. Using the molecular responses of
zebrafish embryos to different IPR water, we report the bioactivity within the water at different stages of advanced
treatment and associate these to perturbed biological functions. Transcriptomic analysis revealed alterations to the
retinoid system, whichwas consistent with the observed teratogenic effects. Changes to tryptophanmetabolism (as-
sociated with the production of melatonin required for the control of normal circadian rhythms) and somatolactin-
beta (associatedwith normal pigmentation infish)were also found.We show that underexplored forms of biological
activity occur in treated wastewater effluent, and/or may be created depending on the type of advanced treatment
process used. By integrating the available analytical chemistry we highlight chemical groups associated to this re-
sponse. Our study shows that more detailed and in-depth characterisation of chemicals and biological pathways as-
sociated with advanced treatment water systems are needed to mitigate possible risks to downstream organisms.
© 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).utledge).
B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Global population growth is placing unprecedented demands on
freshwater sources worldwide, raising concern about the long-term
availability and quality of potable water sources (Brookes et al.,
2014). The South East of England is already experiencing serious
levels of water stress (EA, 2013). Under UK law, water companies
are legally obliged to plan how they will manage the needs of future
populations, deal with climate change (and water supply uncer-
tainty) and develop – where needed – new water supply resources
(Wood et al., 2006). Thames Water Utilities Limited (TW) is one of
12 UK private utility companies responsible for supplying potable
water to 23% of the UK population and providing waste water treat-
ment services to 27% of the UK population (Building a Better Future,
2019). As part of its water resource management plan process, TW
constructed a pilot advanced water treatment plant to determine if
indirect potable reuse (IPR) would be a viable approach in address-
ing the water security problems afflicting the South East of England.
However, before implementing advanced treatment on a large scale,
it is important to determine howmuch treatment is needed to strike
the best balance between generating water that is safe to discharge
into the environment and economic cost (National Research
Council, 1998; Fatta-Kassinos et al., 2011; Dominguez-Chicas and
Scrimshaw, 2010). Consequently, TW commissioned a programme
of research to investigate the biological activity and possible health
effects of exposure to treated water, taken from different stages of
treatment within a pilot IPR water treatment plant.
Planned water reuse is not widely practiced in the UK. However, in
the South East of England treated wastewater is an important compo-
nent of river flow, especially in the summer months and periods of low
water flow, where up to half of a river flow can be composed of treated
wastewater effluent (Jobling et al., 1998). Consequently, unplanned
reuse is typical, because treated wastewater from upstream towns and
cities is abstracted from the downstream river flow in order to be proc-
essed back into drinking water. Advanced treatment via indirect potable
reuse is a further intervention step in the current water reuse cycle. It
aims to remove residual contaminants present in treated sewage effluent
(normally released directly into rivers), using sophisticated physical and
chemical processes before the final product water (FP) is blended back
into an environmental buffer (rivers, surface reservoirs or aquifers).
Advanced treatment is intended tomakewater reuse cycles quicker, pro-
tect the environment and ensure that downstreamdrinkingwater safety
is upheld. In this pilot plant, the different stages of treatment start with
relatively simple and low-cost processes like microfiltration (MF), and
then progress onto more complex and costly processes like reverse os-
mosis (RO) and advanced oxidation (AOP).
The TW brief for this investigation was very broad - to investigate
the safety (or possible health effects) of exposure to indirect potable
reusewater at different stages of the advancedwater treatment process.
Ourfindingswould help to determine howmuch treatment is necessary
to strike the best balance between water safety and economic cost. Our
challenge was to design an experiment that would highlight changes in
biological activity of whole water samples at any stage along the IPR
treatment process, associated with any chemical, at any concentration,
or as part of a mixture effect. We also needed to be able to compare
the biological effects along each of the different treatment stages, in
order to evaluate their relative effectiveness.
Transcriptomic approaches in fish and mammals are gaining in-
creasing traction as away of evaluating the safety ofmunicipal effluents
and drinkingwater (Martinović-Weigelt et al., 2014; Vidal-Dorsch et al.,
2013; Shi et al., 2014). The ability to quantify changes in the expression
of many thousands of genes simultaneously in a single experiment en-
ables toxicologists to identify important biological mechanisms and
predict toxic outcomes caused by exposure to particular compounds
and complex mixtures. Zebrafish continue to be a popular choice of
model organism due to their small size, short generation time, high2
fecundity, and ability to observe well-characterised early stages of de-
velopment in optically transparent embryos ex-utero and the availabil-
ity of established genomic tools and resources (Ruzicka et al., 2019). The
zebrafish genome matches approximately 70% to human orthologs,
supporting their use as a model species for biomedical research
(Arend et al., 2017). For these reasons, zebrafish are increasingly used
in toxicogenomic research (Williams et al., 2014), includingwater qual-
ity and environmental chemical exposure assessment (Caballero-
Gallardo et al., 2016).
Toxicogenomic studies infish illustrate the complex nature of chem-
ical exposures on gene expression in specific tissues and at specific time
points (typically following a short exposure time), corroborating find-
ings from targeted studies (such as induction of VTG by estrogenic com-
pounds) (Katsiadaki et al., 2010; Denslow et al., 1999). However,
transcriptomic profiles and patterns are often complex to interpret in
toxicological studies because chemical-induced biological events lead-
ing to adverse effects occur alongside general responses associated
with cellular stress, apoptosis, and repair on whole genome responses.
Consequently, clear pathways or modes of action, may not always be
easily identified. The duration and timing of exposure, the tissue types
that are analysed and the internal concentration of the chemical being
tested are also likely to influence gene transcriptional profiles, thereby
complicating further our understanding of the specific effects of any
given compound. Moreover, few studies have tried to associate tran-
scriptional changeswith physiological effects, or generally, toxicological
effects at a higher level of biological organisation (Fent and Sumpter,
2011), especially in exposures to complex environmental mixtures.
However, toxicogenomic approaches have been effectively used to as-
sess the toxicity of reconstituted water extracts taken from twomunic-
ipal wastewaters and their receiving water using zebrafish larvae
(Li et al., 2018).
Building on this knowledge, and to address this brief, we investi-
gated the residual toxic biological effects of each treatment stage, by
monitoring deviances away from normal development in zebrafish em-
bryos exposed from fertilisation and throughout early development
(Braunbeck and Lammer, 2006) – life stages that are particularly sensi-
tive to disruption by chemicals, as explained by the ‘foetal origin of dis-
ease’ (Grandjean, 2008). Our strategy was to compare phenotypic
observationswithwhole transcriptome responses in zebrafish through-
out early development. Contrary to a single exposure time point (Li
et al., 2018), our sampling approach extended throughout develop-
ment, thereby improving our mechanistic understanding of the dy-
namic effects of treatment on key biological pathways related to
health. Our approach differs substantially from targeted methods to as-
sess the impacts of chemicals inwater-treatment processes that employ
a multiplicity of in vitro assays designed to capture different mechanis-
tic endpoints (Escher et al., 2014; Dong et al., 2019) (e.g. nuclear recep-
tor binding, enzyme inhibition, genotoxicity, cytotoxicity) and that
enrich organic chemicals from the water using Solid Phase Extraction
(SPE) thereby removing inorganics and altering the composition of
the sample. Instead, we use whole water samples, without any form of
additional treatment or extraction, so that both organic and inorganic
phases are included. Although this study was not intended to identify
chemical agents responsible for biological effects (e.g. using an Effects
Directed Analysis approach (Desbrow et al., 1998)), we used available
pilot plant water chemistry data obtained around the time that water
samples were collected to determine whether observed transcriptomic
responses could be explained by the measured organic and inorganic
chemicals.
Our innovative approach enabled us to keep an open mind about
which chemicals contained within the water at each sample stage
might be influencing key biological pathways during early develop-
ment. This resulted in both confirmatory data as well as identification
of less obvious, and less studied, biological pathways associated with
the residual effect, providing an improved understanding of real-
world mixtures on biological systems during early development.
Fig. 1. (A) Schematic of the IPR plant showing chloramine dosing points (٭) and positions
(1–6) where composite samples or grab samples were taken. B) Principal component
Analysis (PCA) plots of Quantile normalised data showing the large effect of
developmental stage (4, 8, 12, 16, 24, 36 and 48 hpf) on gene expression in embryos
exposed to different IPR product waters, tap and control. (C) Principal component
Analysis (PCA) plot of cyclic loess normalisation PCA plot of data normalised against
aquarium water to reveal the effects of the IPR treatment alone. In each case, each point
represents the integrated expression of 15,000 genes.
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2.1. Overall approach
A general summary of the overallmethodological approach is shown
in Fig. S1. We reared zebrafish embryos in various product waters sam-
pled along the IPR pilot plant process, or aquarium water and a tap
water as source of the aquarium water. Survival and developmental
anomalieswere recorded in each case at different stages throughout de-
velopment. A detailed transcriptomic analysis was used to identify
which geneswere differentially expressed relative to the aquarium con-
trol water at each stage of development, and to identify key biological
pathways altered by each treatment. By integrating perspectives gained
from the transcriptional and developmental anomalies, we are able to
propose mechanisms of action, and test these using toxicological ap-
proaches by exposing zebrafish embryos to chemicals detected in the
treatment water and/or with a known mode of action.
2.2. Pilot IPR facility
Thames Water Utilities' 600 m3 d−1 IPR pilot plant was commis-
sioned in 2008 to generate data for any future plans to operate a full-
scale project. The pilot IPR plant received final effluent from a conven-
tional activated sludge plant processing domestic wastewater from a
population of circa 870,000 at the time of study (personal communica-
tion Marie Raffin, Thames Water, UK).
The Sewage Treatment Works final effluent that feeds the IPR plant
is pre-filtered using a 500 μm coarse filter, and then is filtered more
finely through a microfiltration membrane (MF) process (Raffin et al.,
2011). Chloramine is used to minimise biofouling in the pipework and
equipment (Raffin et al., 2012), and can be added to the final effluent
before and after pre-filtration, and after MF (Fig. 1A). After MF, one
stream of MF permeate is treated with anti-scalant and sulphuric acid,
before passing through a reverse osmosis (RO) membrane. It then
goes through an Advanced Oxidation Process (AOP) where it is
disinfected by ultraviolet light and dosed with hydrogen peroxide
(AOP2). Finally, this stream (referred to as Final Product or ‘FP’) is
corrected for pH and degassed. A second stream of MF permeate goes
directly to a separate AOP system without reverse osmosis or anti-
scalant/sulphuric acid (AOP1) and is the final product of this particular
stream. The IPR plant was fully automated, with advanced water sam-
pling instrumentation tomonitor and control theprocess, and onsite su-
pervisory control and data acquisition (SCADA) system to record trends
and collect data on quality at various stages of the process for analysis in
real time. As part of the continuous quality control of the IPR Plant TW
generates chemical analytical data on a regular basis. We extracted
the closest available date of available chemistry which coincided with
data 24 h before completion of our 24 h composite sampling and thus
represents the available chemicals in our samples very closely. Available
water chemistry data has been summarised in Table S7. For privacy
purposes, the specific lab and date of analysis have been removed
from the table, and duplicated chemicals aremeasurements bymultiple
laboratories.
2.3. Water sample collection
We collected 24 h composite IPR plant's water samples using auto-
mated samplers set at 4 °C and stored these at 4 °C until needed
(between 12 and 24 h after collection). General physicochemical prop-
erties of the aquarium control, tap water and IPR plant exposure waters
are shown in Table S1. Water samples were sent to an approved labora-
tory by TW for routine chemical analysis, to identify compounds ex-
ceeding the Limit of Detection (LOD) (summarised in Fig. S4). Free
chlorine in tap water was allowed to dissipate by letting the sample
stand for 24 h before use.3
2.4. Zebrafish culturing and spawning
We sourced adult zebrafish (Danio rerio) (Tübingen strain) from
University College London (UCL, UK). The fishwere separated according
to sex and placed into 10 l flow-through tanks receiving dechlorinated
carbon-filtered (5 and 10 μm) tap water (aquarium header water) fed
fromheader tanks at aflow rate of 20 l/h at 26–28 °Cwith a photoperiod
of 14 h Light:10 h Dark. Fish were fed 3 times a day; twice with flake
food (King British Tropical flake food, Lillicos, Surrey) and once with
adult brine shrimp (TropicalMarine Centre, Gamma irradiated). All tub-
ing (flow-line, air-lines, siphon, and the attached grids) are made of
medical grade silicon (VWR, UK).
To induce spawning, we placed sexually mature male and female
adult zebrafish together overnight in 9.5 litre breeding tanks at a ratio
of 2 males to 4 females. Each breeding tank was fitted with a metal
grid allowing the eggs to fall to the bottom of the tank. We selected
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after dawn) and placed the embryos (aged between 1 and 2 hour post-
fertilisation) into 300 ml crystallising dishes containing aquarium
water. All procedures were performed in compliance with the Animals
(Scientific Procedures) Act 1986 and institutional guidelines following
appropriate institutional committee approval. The research was con-
ducted with ‘Animal Research: Reporting In Vivo Experiments’ (AR-
RIVE) guidelines (Kilkenny et al., 2013) in mind.
2.5. Temporal effects of IPR water exposure on development
In order to investigate the phenotypic effect of exposure we took
various physicochemical readings including dissolved oxygen (HACH
oxygen and temperature probe), pH, general hardness, carbonate, ni-
trate, and nitrite (API 5 in 1 test strips), and ammonia (API ammonia
test strips) in water samples at the start of every exposure. Wewarmed
a 24-well plate containing 2 ml of an IPR product water/well (or aquar-
ium header water control or tap water) to 28 °C in an incubator while
newly fertilised embryos were collected and sorted.We placed one em-
bryo into each well and took temperature readings inside the incubator
at the start of the exposure with a thermometer, as well as continuous
readings throughout the experiment using two Tiny Tag data loggers.
We observed embryos at time intervals (4, 8, 12, 16, 24, 36, and 48
hour post-fertilisation (hpf)) using a LeicaMZ FL III fluorescence stereo-
microscope and the Leica DC 300F digital image recording system.
Deviances away from normal developmental expectations at each
time point were recorded. The experiment was repeated three times
over a period of 3months. The endpointswe used to categorise embryos
as ‘normal’ or ‘abnormal’ came from a number of sources (Table S2), in-
cluding the OECD background document for the fish embryo toxicity
tests (Braunbeck and Lammer, 2006; Nagel, 2002; Schulte and Nagel,
1994; Braunbeck and Lammer, 2005). Differences in the frequency
and severity type of abnormalities (namely, Severe - curvature of the
spine/twisted spine; malformed head; enlarged heart; no tail; stunted
tail; no otolith development; gap in yolk sac. Sublethal - no eye develop-
ment; enlarged yolk sac; blood clot in the heart; reduced body pigmen-
tation; reduced eye pigmentation; misshapen eyes. Lethal - no somites;
no head) in the total population of zebrafish embryos exposed to the
different waters were compared using the Diversity Permutation Test
in PAST v3.17 software (Hammer et al., 1999) using the Simpson Biodi-
versity Index. This approach enabled us to compare the diversity of ab-
normalities (both frequency and thenumber of different types) found in
each treatment group. At 48 h, we transferred the exposed groups of
embryos into RNAlater® stabilisation solution (Life Technologies, UK)
at 4 °C for 24 h and then stored them at−80 °C.
2.6. IPR water exposures for gene expression analysis
2.6.1. Embryo exposures and sample preparation
To characterise the transcriptomic profiles we randomly allocated
50 embryos to 200 ml of IPR water (and aquarium and tap waters) in
300 ml glass crystallising dishes and used a glass petri dish as a lid.
Dishes were incubated at 28 °C in large fish tanks receiving a flow of
heated water from the header tanks. Every IPR product water (FE, MF,
AOP1, RO, AOP2, FP) and reference water samples (Brunel University
London aquarium and tapwater) consisted of six independent sampling
time-points (at 8, 12, 16, 24, 36 and 48 hour post fertilisation), carried
out in duplicate, resulting in 96 dishes for each experiment.We sampled
embryos throughout development to capture transient biological effects
occurring during embryogenesis of possible relevance to the abnormal-
ities seen.
At each time point, we photographed one ‘normal’ embryo from
each dish and counted and removed any dead embryos. Abnormal em-
bryos were photographed and preserved individually in RNAlater®
(0.6ml/embryo) in case theywere needed at a later date. Finally, the re-
maining embryos were pooled and preserved together in 1.4 ml of4
RNAlater®. It was decided not to include RNA from phenotypically ab-
normal embryos in themicroarrays as theymay have a disproportionate
effect on the pooled sample. We carried out three independent expo-
sures over a period of approximately one month.
2.6.2. RNA extraction and hybridization
WeextractedRNAusing theRNeasyMini Kit (QIAGEN,USA) following
the manufacturer's protocol for the preparation of RNA from tissue
(QIAGEN, 2012) with modifications for use with fish embryos. Briefly,
embryos were removed from the −80 °C freezer and defrosted on ice,
after which we removed the RNAlater® using a pipette. We then
homogenised the embryos using 350 μl Buffer RLT (containing 10 μl β-
mercaptoethanol/ml of buffer) by repeatedly drawing up and dispensing
the mix using a 1 ml syringe. To prevent the filter from blocking, we
passed the resulting lysate 10 times through a blunt 20-gauge needle
(0.9 mm diameter) and used “On-Column DNase Digestion with the
RNase-Free DNase Set” to recover the RNA. Finally, we eluted the RNA
from the column with 36 μl RNase-free water. We quantified RNA yield
using a Thermo Scientific NanoDrop™ 1000 Spectrophotometer and
visualised the RNA purity and quality by electrophoresis (1.5% agarose
gel with ethidium bromide). We used a One-Color Microarray-Based
Gene Expression Analysis Low Input Quick Amp Labelling kit supplied
by Agilent Technologies, with a final concentration of 75 ng/μl total
RNA. The procedure included the following steps; cDNA synthesis, cRNA
synthesis and amplification, cRNA purification, preparation of hybridiza-
tion sample, 17hourhybridization (65 °C),wash, scan, and feature extrac-
tion (Agilent, 2014). The data discussed in this publication have been
deposited in NCBI's Gene Expression Omnibus (Edgar, 2002) and are ac-
cessible through GEO Series accession number GSE152131 (https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152131).
2.6.3. Pre-processing and statistical analyses
We normalised and analysed our data using the statistical program-
ming environment R (R Core Team, 2016). The two different normalisa-
tion approaches were: 1) quantile normalisation (‘normalize.quantiles’
function from the preprocessCore package) and 2) cyclic loess normal-
isation against their respective experimental and developmental stage
control (‘normalizeWithinArrays’ function in the limma package). The
expression level of each gene, within each treatment group and time
point, are normalised against their corresponding aquariumwater con-
trol group gene. We did not normalise gene expression along the IPR
treatment to tap water, because chemicals present in IPR samples may
occur in tap water, thereby potentially masking residual transcriptomic
effects along the advanced treatment process. Loess normalisation takes
into account the effect of development on the molecular response, and
in doing so will emphasize the effect of treatment. We used principal
component analysis (PCA) to reduce the overall dimensionality of data
and for visualisation purposes.Weanalyseddifferential gene expression
using the Significance Analysis for Microarrays (SAM) methodology as
implemented in the samr package (Tusher et al., 2001). To identify indi-
vidual genes that are differentially expressed at each developmental
time point along the treatment process (expressed as log-fold changes),
we carried out a two-group comparison in limma on each individual
gene expression dataset against their corresponding control (e.g. 8 h
AquariumWater against 8 h Final Product).
2.6.4. Time-course and pseudo-time-course analysis
Tohelp identify geneswhose relative expression gradually increased
or decreased during development (8 h–48 hpf) in each of the IPR treat-
ments, we used a time-course analysis in the samr package (Tusher
et al., 2001). For the pseudo-time-course analysis we assumed that a re-
lationship between the different treatments is present.We only focused
on the following direction of flow ‘Pre-MF-RO-AOP2-FP’ and repeated
the analysis for each timepoint. This enabled us to identify genes that
change across the direction of treatment for each timepoint, to highlight
genes responding gradually to change along the treatment process.
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Unlike the time-course type analysis, an ANOVA will identify any
significant change at any treatment position or time-point. To aid in bi-
ological interpretationwe used pathway indices as an input to a 2-factor
ANOVA on both the quantile and loess normalised data.We only consid-
ered pathways for which more than 5 genes were present for further
analysis:
pathway ¼ stagedev þ treatment þ stagedev ∗ treatment þ experiment
where ‘stagedev’ represents the developmental stage of the fish (hpf),
‘treatment’ the stage in the IPR plant (i.e. positions 1–6 in Fig. 1A) and
‘experiment’ the day on which the experiment was performed. We ad-
justed the p-values using a False Discovery Rate (FDR) correction
(Benjamini and Hochberg, 1995) using the p.adjust function in R.
2.6.6. Linking gene expression changes across IPR stages
To identify whether there is a relationship between the available
chemistry and gene expression profiles that we developed, Pearson cor-
relationwas used. First chemical concentrationswere transformedwith
log10 and then combined with each individual gene within our dataset.
For those comparisons where sparsity resulted in <6 overlapping sam-
ples, and where the variation within the chemical concentrations was
below 0.1 were removed to ensure that only relevant connections
were identified. Resulting list was filtered for correlations with at least
an |r| > 0.75. The resulting connections were then represented as a
graph and visualised using Cytoscape.
2.7. Developmental exposures to known chemicals
Following detailed evaluation of the responses of zebrafish embryos
to IPR treatment waters, we exposed zebrafish embryos up to 48 hpf to
specific chemicals based on (i) their presence in treatment waters and/
or (ii) reportedmode of action, in order to corroborate the genomic and
phenotypic effects we observed based on the literature (Fig. S1).
Propiconazole (an antifungal), ibuprofen (NSAID) and ER50891
(retinoic acid receptor alpha antagonist) were chosen for these tests,
and the rationale these choices is explained further in the Results sec-
tion. All chemicals were analytical grade standards and were tested
using three doses based on environmental relevance (if known). WeTable 1
Total percentage of different abnormalities detected in embryos at 48 hpf exposed to aquarium
plant (Final Effluent (FE); Microfiltration (MF); Advanced Oxidation (AOP1); Reverse Osmosis
were recorded from 6 independent experiments using two different approaches (individual em
over a period of fourmonths. Number of abnormal embryos and the total number analysed: FE
Differences in total number of embryos are due to a combination of early mortality, technical d
malities is based on Braunbeck and Lammer (2005), Nagel (2002) and Schulte and Nagel (19
NT: no tail; NO: no otolith development; NE: no eye development; EY: enlarged yolk sac; BC




CS T 0.00 0.41 0.40
MH T 0.00 0.00 0.00
EH T 0.00 0.00 0.40
NT T 1.01 0.00 0.40
NO T 1.01 0.00 0.00
NE SL 1.01 0.00 0.00
EY SL 0.00 0.00 1.19
BCH SL 0.00 0.00 0.40
NP SL 2.01 0.41 0.00
NC SL 1.01 0.00 0.00
NM SL 1.01 0.00 0.00
NS L 1.01 0.00 0.00
NHB L 1.01 0.00 0.00
UT L 1.01 0.00 0.00
5
prepared a master stock of 4-[5-[8-(1-Methylethyl)-4-phenyl-2-
quinolinyl]-1H-pyrrolo-2-benzoic acid (ER50891 - 250 mg/l; Tocris,
UK - ≥99% purity) by dissolving 2.5 mg of chemical in 10 ml analytical
grade DMSO, and made working stocks of 20, 10 and 5 mg/l ER50891
by diluting the master stock further with DMSO. We aliquoted 20 μl of
each working stock (or DMSO solvent control) into acid and solvent
rinsed Pyrex dishes in triplicate and added 200 ml of aquarium water
to produce final ER50891 nominal concentrations of 2 μg/l, 1 μg/l and
0.5 μg/l (0.01%DMSO). The same approachwas used to expose develop-
ing zebrafish embryos to Propiconazole (≥99% purity; Sigma-Aldrich,
UK; nominal doses 0, 0.1, 1.0 and 10 mg/l), and Ibuprofen (≥99%;
Sigma-Aldrich, UK; nominal doses of 0, 4.0, 40 and 400 μg/l). We
added 50 fertilised embryos (between 1 and 2 hpf) to each dish using
a Pasteur pipette, and placed them into an incubator set at 28 °C for
48 h. Up to three independent exposures were carried out with embryo
observation as described in Section 2.6.1.
3. Results
3.1. Water physicochemistry across IPR stages
Ammonia (0–3 mg/l), nitrate (40–80 mg/l), nitrite (0–3 mg/l) and
hardness (180–240 mg/l) were highest in the early stages of treatment
(Final Effluent to AOP1) with pH levels of 7.5–8.0.Water samples taken
after RO treatment had decreased pH (6.0–7.0), hardness (0–40 mg/l),
ammonia (0–1 mg/l), and nitrite and nitrates were non-detectable.
The RO and Final product were similar in all measurements taken. Tap
water and aquarium water had pH and hardness levels similar to final
effluent, and ammonia, nitrate, and nitrate levels similar to the RO and
Final Product waters (see Table S1).
3.2. Characterisation of abnormalities in zebrafish embryos exposed to IPR
water
The mean frequency of spontaneous abnormalities in all exposed
embryos at 48 hpf was typically low, ranging from 0% (control and
RO), 2.3% and 2% in tap water and final effluent, respectively, and
reaching 3.7% in the AOP2 treatment.We observed differences in abnor-
mality types and severity class (Teratogenic, Lethal and Sub-Lethal)
during advanced treatment, and in the tap water (Table 1), withoutcontrol water (AqC), Brunel tap water (TAP), and treatmentwater taken from the IPR pilot
(RO); Advanced Oxidation with RO (AOP2) and Final Product Water (FP). Abnormalities
bryos placed in 24-well plates or groups of 50 embryos in petri dishes). Data was collected
4/199;MF 2/246; AOP1 4/252; RO 0/258; AOP2 7/188; FP 1/182; TAP 6/263 and AqC 0/248.
ifficulties in sample collection, and/or the availability of embryos. Classification of abnor-
94). CS: curvature of the spine/twisted spine; MH: malformed head; EH: enlarged heart;
H: blood clot in the heart; NP: no pigmentation; NC: no circulation; NM: no movement;
b-Lethal (SL) and Lethal (L).
ss Waters Reference
RO AOP2 FP TAP AqC
0.00 1.60 0.00 1.14 0.00
0.00 0.00 0.00 0.38 0.00
0.00 0.53 0.00 0.00 0.00
0.00 0.00 0.55 0.00 0.00
0.00 0.00 0.00 0.38 0.00
0.00 0.00 0.00 0.38 0.00
0.00 1.06 0.00 0.00 0.00
0.00 1.06 0.00 1.14 0.00
0.00 0.53 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.38 0.00
Table 3
Comparison of expression of differentially regulated genes identified in embryos exposed
to tapwater and product waters from the IPR treatment process at different developmen-
tal stages (hours post fertilisation; hpf) compared to their respective aquariumwater con-
trol. Analysis carried out using a two-group comparison in Limma using the ‘toptable’
function on each individual gene expression dataset against their corresponding control.
Only time points where one or more genes were differentially expressed using this anal-
ysis are shown. ↑ denotes up-regulation and↔ denotes no change in regulation. For more
information (including log-fold change) see Table S3.
Treatment hpf Cytochrome 
P450, family 1, 
subfamily A
Cytochrome 




FE 12 ↑ ↑ ↔
24 ↑ ↔ ↔
48 ↑ ↔ ↔
MF 12 ↑ ↑ ↔
24 ↑ ↔ ↔
36 ↑ ↔ ↔
48 ↑ ↔ ↔
AOP1 12 ↔ ↑ ↔
24 ↑ ↔ ↔
48 ↑ ↔ ↔
RO 48 ↔ ↔ ↑
AOP2 48 ↔ ↔ ↑
FP 48 ↔ ↔ ↑
Tap 48 ↔ ↔ ↑
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mality types observed in the embryos exposed to FE, MF had 2 of these,
AOP1 and AOP2 each had five, RO had none, FP had one (teratogenic)
and tapwater had six. Like RO, no abnormalitieswere seen in theAquar-
ium water. The abnormalities could be broadly classified into skeletal
anomalies (curvature of the spine, absence of otolith development or
absence of a tail – see Fig. S2B), cardiovascular anomalies (e.g. enlarged
heart, pericardial oedema, and blood clot in heart – see Fig. S2C), and
pigmentation effects (e.g. an absence of pigment - see Fig. S2D). Signif-
icant differences in the diversity (frequency and type) of abnormalities
occurred between different treatment groups (Table 2); most notably
the source water (Final Effluent) had significantly more abnormalities
compared to all other waters (except Tap), and the aquarium control
water had significantly fewer abnormalities compared to the other wa-
ters (excluding MF, RO, and FP).
3.3. IPR exposure affects key drug metabolism components and
somatolactin-β
To understand the effect treatment and developmental stage had on
our zebrafish we initially visualised the samples using PCA plots. Em-
bryo development had the most profound effect on the molecular re-
sponses relative to any other variable, including exposure to IPR water
treatment, replicates, and experiment number (Fig. 1B). To resolve the
effect of exposure to the different water treatment stages, we loess nor-
malised each of the treatments against their respective control samples.
This accounts for possible uncontrolled variables during the experimen-
tal period, and thereby reveals differences in gene expression caused by
exposure to the different IPR product waters (Fig. 1C).
For each developmental stage and IPR treatment process we identi-
fied individual genes that were up and down regulated relative to the
aquarium control (Table 3). Somatolactin-β was up-regulated at 48
hpf in the embryos exposed to tap water, FP, AOP2 and RO product wa-
ters. Somatolactin-β gene transcription remained unchanged at all
other time points and in the embryos exposed to the other product wa-
ters. Cytochrome P450, family 1, subfamily A was also up-regulated in
embryos exposed to early treatment stages (FE, MR and AOP1), and at
various developmental time points (Table 3). Cytochrome P450, family
1, subfamily B was up-regulated in all the same treatments, but only at
12 hpf.
In order to establish (i) whether differences occurred in global gene
expression between treatments, and (ii) which treatment stages were
most dissimilar with other treatment stages, the smallest FDR value as-
sociated with statistical significance between treatments was selected.
In this analysis, the lower the FDR themore likely a statistical difference
between the molecular responses is observed, and that this is true.
While this does not include the number of genes, it does include the
highest observed statistical difference, and can act as a guide of dissim-
ilarity across the treatments. Fig. 2A illustrates the most significant dif-
ferences in global gene expression, indicated by the red arrows at the
top of the flow chart and the FDR value beside the arrow; the greenTable 2
Differences in the frequency of different abnormalities in zebrafish embryos exposed to
treated final effluent (FE), advanced treatment water (MF, AOP1, RO, AOP2, FP), a tap wa-
ter and associated aquariumwater using the Diversity Permutation Test in PAST software
and the Simpson Index as ameasure of differences in the diversity of abnormalities in each
treatment group. Red boxes P < 0.05 and blue boxes P < 0.1.
MF AOP1 RO AOP2 FP Tap AqC
FE 0.0001 0.0023 0.0001 0.003 0.002 0.123 0.0001
MF X 0.1589 0.2371 0.6552 1 0.0309 0.5013
AOP1 X 0.0164 0.343 0.1166 0.5616 0.0149
RO X 0.0753 0.6207 0.0017 1
AOP2 X 0.6327 0.1622 0.0813




arrows underneath the flow chart show where the differences in gene
transcriptional responses between treatments were much less pro-
nounced. In general, the smallest FDRs occurred between treatments
that were further apart along the IPR process, for example final effluent
(following a pre-filtration step) and final product (FDR of 0.11). How-
ever, microfiltration and reverse osmosis are “next” to each other in
the IPR treatment process and have amuch lower FDR (0.15), indicating
that the statistical differences in gene expression between these treat-
ments are more likely to be true. Certain treatment processes (such as
microfiltration of pre-filtered final effluent) appeared to show no mea-
surable effects on global gene responses compared to embryos exposed
to final effluent (FDR 1.06). In contrast, therewas a strong statistical dif-
ference between post-MF and the final product water (FDR 0.08).
Therefore, global gene responses to pre-filtered final effluent and
microfiltration are much more similar to one another compared to
treatments further along the process. No substantial differences were
observed in global gene expression between reverse osmosis and
AOP2 (FDR 1.13) and AOP2 and final product (FDR 1.24).3.4. Pathway analysis identifies additional developmental and metabolic
pathways
To better characterise the exposure system, we opted to analyse the
response on the level of pathway indices. Here instead of using single
gene expression we summarise the activity of a pathway of multiple
genes into a single variable and used that as an input to an ANOVA.
Using this approach, we assessed the influence of each experiment (1,
2 or 3), developmental stage and IPR treatment stage on pathway indi-
ces. Quantile and loess normalised data revealed 329 and 269 pathway
indices to be differentially expressed based on experiment, and 392 and
289 pathways indices to be differentially expressed due to developmen-
tal stage, respectively. In contrast, the number of pathway indices that
were differentially expressed in repeat experiments based on IPR treat-
ment process (sample) was only 10 and 5 using the quantile and loess
normalised data, respectively. These pathways were all broadly in-
volved in hormone synthesis/metabolism and detoxification (see
Table 4).
Fig. 2B shows differences in genepathway responses between differ-
ent treatments at different stages of development using the FDR as a









Fig. 2. A. Illustration of the IPR treatment plant with the selection of the minimum FDRs for loess normalised dataset using SAM time-course analysis at gene level using the signed
approach. The lower FDRs indicate larger difference in global gene expression between treatment stages. The complete list of minimum FDRs are displayed in Table S4. B. Illustration
of the IPR treatment plant with the selection of the minimum FDRs for quantile normalised dataset using SAM time-course analysis at pathway level using both the signed and slope
approach. The FDRs shown on the figure are significantly different. The complete list of minimum FDRs are shown in Table S5.
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using this analysis approach. These included differences between the
pre-filtered final effluent and the final product water (FDR 0.17), and
between the microfiltration and final product water (FDR 0.12). A sig-
nificant difference in gene pathway responses were also observed be-
tween the two AOP treatments (FDR 0.19), where the product water
from the AOP2 process had previously undergone microfiltration and
the addition of anti-scalant and sulphuric acid prior to reverse osmosis,
whereas the product water from the AOP1 treatment had undergone
microfiltration alone. FDR values were typically higher in all other com-
parisons, which indicates that there is a higher proportion of type 1 er-
rors, and therefore a higher probability of recording a false positive in
these comparisons.
We used a pseudo time-course to identify differentially expressed
pathways along the entire treatment process at each developmental
time point using the quantile-normalised dataset. This approach iden-
tifies genes that change across the direction of treatment for each
timepoint, to then assemble pathways that are responding gradually
to change along the treatment process. The time-course followed the
treatment order FE → MF → AOP1 → RO → AOP2 → FP → Control.Table 4
2-Factor ANOVA Pathway level. The ‘+’ means that the corresponding pathway was differen
methods of analysis.
Pathways Quantile normalised data m
Exp 1 Exp 2
Steroid hormone biosynthesis + +
Tryptophan metabolism +
Retinol metabolism + +
Metabolism of xenobiotics by cytochrome P450 + +
Drug metabolism-cytochrome P450 +
Drug metabolism-other enzymes +
7
Melanogenesis pathways were down-regulated at 12 h whereas the
Hedgehog signalling pathwaywas upregulated at 36 h. Tryptophanme-
tabolism (used in the synthesis of brain neurotransmitters melatonin –
modulator of circadian rhythms – and serotonin)was also altered at dif-
ferent stages of development along the treatment process. The most
commonly altered pathways affected by treatment during development
were changes to purine and pyrimidine pathways associated with
maintenance of nucleotide levels in tissues (Table S6).
3.5. Analytical chemistry associated to biological responses
In order to test whether the observed responses could be explained
by the associated chemistry, we retrieved the routine chemical concen-
trations, developed by TW during the sampling period, and correlated
these to the observed gene expression. Out of the 178 analytical mea-
surements undertaken, as part of the chemical analysis, we focused on
57 with sufficient variance and availability to correlate with gene ex-
pression profiles. Chemicals that did not change between the three sam-
pling dates, or chemicals for which many of the datapoints were below
the level of detectionwere removed. Fig. 3 visualises the outcome of thistially expressed in the embryos from experiment (Exp) 1, 2 or 3 using the two different
ethod Loess normalised data method
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Fig. 3.
Correlation network representing the relationship between chemical analytical features and gene expression profiles. Nodes marked in purple represent the chemistry and nodes in blue
genes. Closely positioned nodes are highly correlated with each other. To identify the functional enrichment of genes associated to the analytical chemistry the first neighbours of closely
positioned analytical chemistry nodes where performed. The resulting pathways are highlighted underneath the node group description shown. For further detailed annotation of
chemical analytical features and gene expression profiles please see Fig. S3. (For interpretation of the references to color in this figure legend, the reader is referred to the web version
of this article.)
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terestingly, N-Nitrosodimethylamine was associated with T-cell differ-
entiation and steroid hormone biosynthesis relevant genes which has
long been a known landmark of NDMA exposure (Desjardins et al.,
1992). Carbendazim and Diuron, which are a fungicide and algicide re-
spectively, were closely related to cell communication, nervous system
processes, and endocytosis functions; all hallmarks of this subtype of
chemicals. A closer look across much of the responses identified in this
analysis highlighted drug and retinol metabolism linked to metal and
metalloids responses as well as water characteristics (Fig. 3).
3.6. Exposure to a retinoic acid receptor alpha antagonist (ER50891) repli-
cates abnormalities
Our analysis identified drug metabolism-relevant pathways associ-
ated to the different exposures across the IPR treatment plant. More-
over, our analysis (Fig. 3) highlighted the potential genes and
functions that directly link to water quality parameters measured, and
showed that the previously identified drug metabolism pathways
were associated with metalloids and transition metals. In the same
group we also identified steroid hormone biosynthesis and the retinol
metabolismpathways. The variety and type of abnormalities seen (skel-
etal, craniofacial, cardiovascular and pigmentation) indicated disruption
to critical pathways in early morphogenesis, and therefore the retinoid
system was selected for further investigation.
To test the hypothesis that disruption to the retinoid system was a
key mechanism responsible for the abnormalities observed in embryos8
reared in the IPR process water, we exposed developing zebrafish em-
bryos to ER50891 (a retinoic acid receptor alpha antagonist),
Propiconazole (a triazole fungicide), and Ibuprofen (a non-steroidal
anti-inflammatory drug; NSAID). Propiconazole was chosen because it
is reported to reduce hepatic retinoid levels in mice (Chen et al., 2009)
by disrupting Cyp26-induced inactivation of endogenous retinoic acid
in tissues with associated skeletal effects (Novák et al., 2008;
Menegola et al., 2006) and because azole fungicides were detected in
the raw water input of the IPR pilot plant (e.g. Clomitrazole -
Table S7). Ibuprofen was tested because non-steroidal anti-
inflammatory drugs (NSAIDS) are widely detected in the environment
(Corcoran et al., 2010), have known cardiotoxicity associated with
COX-2 inhibition (Jane Mitchell et al., 2019; Zhang et al., 2020) and
wasmeasured in the rawwater input (see Table S7). Although notmea-
sured in the IPR water, ER50891 was chosen because it is known to in-
hibit effects of endogenous retinoic acid by binding to the retinoic acid
receptor (Kikuchi et al., 2001). Developmental exposure to
Propiconazole and Ibuprofen did not cause clear dose-dependent in-
creases in abnormalities seen in the IPR and tap waters (see Table S8),
although there was evidence of pigmentation reduction in a small pro-
portion of embryos exposed to propiconazole and cardiotoxicity with
Ibuprofen at the highest dose. In contrast ER50891 caused a dose-
dependent increase in the frequency of abnormal embryos from 3.4%
in 500 ng ER50891/l to 12.6% in 1 μg/l (Table 5). Furthermore, multiple
abnormalities were observed in the embryos exposed to ER50891 that
were also seen in the embryos exposed to AOP1, AOP2 and tap water,
including skeletal malformations (curved spine, no tail, malformed
Table 5
Frequency of abnormalities detected in zebrafish embryos exposed to nominal concentrations (500 ng/L and 1mg/L) of a selective retinoic acid receptor (RARα) antagonist ER50891 and
the solvent control (SC: DMSO, 0.01% final concentration) after 24 h and 48 h post fertilisation. Number of abnormal embryos and total number analysed at 48 h: SC 3/146; 500 ng/L 11/
324; 1000 ng/L 17/134. Classification of abnormalities was based on Braunbeck and Lammer (2005), Nagel (2002) and Schulte and Nagel (1994). Teratogenic (T) - CS: curvature of the
spine/twisted spine; MH: malformed head; EH: enlarged heart; NT: no tail; ST: stunted tail; NO: no otolith development; GYS: gap in yolk sac. Sublethal (SL) - NE: no eye development;








Abnormality Severity 24 hpf 48 hpf 24 hpf 48 hpf 24 hpf 48 hpf 24 hpf 48 hpf
CS T 0.68 1.37 1.49 3.73 4.48 2.99 4.05 1.35
MH T 0.68 0.00 5.22 2.24 8.21 0.75 4.05 0.68
EH T 0.00 1.37 0.75 4.48 9.70 9.70 8.78 4.05
NT T 0.00 0.00 7.46 1.49 6.72 3.73 3.38 2.03
ST T 0.00 0.68 0.75 0.75 9.70 2.24 1.35 0.68
NO T 0.00 0.00 7.46 0.00 6.72 2.99 1.35 1.35
GYS T 0.68 0.00 3.73 1.49 10.45 3.73 4.73 0.00
NE SL 0.68 0.00 4.48 0.00 5.22 0.75 1.35 0.00
EY SL 0.00 0.68 4.48 0.75 8.21 0.75 0.68 0.00
BCH SL 0.00 0.68 0.00 1.49 0.00 0.75 0.00 1.35
RPB SL 0.00 0.00 2.99 0.00 0.75 0.00 0.00 0.00
RPE SL 0.00 0.00 0.75 0.00 3.73 0.00 0.00 0.00
ME SL 0.00 0.00 0.00 0.00 0.75 0.00 0.00 0.00
NS L 0.00 0.00 7.46 0.75 7.46 3.73 2.70 2.03
NH L 0.00 0.00 5.97 0.00 2.99 1.49 0.68 0.00
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heart), and reduced body and eye pigmentation.
4. Discussion
TW's broad research question inspired us to take the ambitious step
of departing from traditional hypothesis-led approaches and to investi-
gate the IPR treatment processwith nopre-conceptions in favour of par-
ticular chemicals or specific biological effects. Our aimwas to determine
if phenotypic abnormalities could be related to specific transcriptomic
pathways associated with toxicity, at different stages of embryonic de-
velopment, in zebrafish exposed to whole water samples taken along
the entire IPR process. Such an approach has not been attempted before.
4.1. Zebrafish survival and abnormalities throughout the IPR process
The zebrafish embryos survived equally well in water taken from all
treatment stages, indicating that no acute toxicity occurred to the devel-
oping embryos along the entire treatment process. Nevertheless, a small
number of distinctive spontaneous abnormalities (~1–2% frequency)
occurred in the IPR treatment groups with the exception of RO where
no abnormalities were seen. These included teratogenic abnormalities,
such as altered pigmentation, cardiovascular anomalies and skeletal de-
formities that were not observed in the embryos exposed to aquarium
control water. Their occurrence and association to the IPR process
water was only apparent because of the large number of fish embryos
used in our studies. Often, in IPR process waters, multiple abnormalities
occurred together within a single embryo which is why the total num-
ber of abnormalities detected is greater than the total number of abnor-
mal embryos.
Interestingly, exposure of the embryos to a tapwater (introduced for
a comparison with the final product waters; AOP1 and FP) produced a
low incidence of the same types of abnormalities seen in embryos ex-
posed to the IPR process waters, and in particular AOP1 and AOP2. As
the tap water was supplied by a different water utility company, it
would have been more appropriate to use tap water from the same
source (being the end-of-pipe product from unplanned reuse from the
same catchment area). Notwithstanding, as the FP water from indirect
potable reuse is not intended for direct municipal supply, the tap
water comparison has little relevance with respect to current reuse9
scenarios. Moreover, the significance (if any) of these findings to
human health would need to be the subject of a much more thorough
investigation.
4.2. Relationship of IPR water physicochemistry to the observed effects
It is conceivable that changes to the physicochemical properties of
the water (e.g. pH, nitrite) along the IPR process (Table S1) may have
caused the observed teratogenic abnormalities. However, zebrafish em-
bryos tolerate a wide pH range (between 6.0 and 8.5) and wild popula-
tions occur naturally in waters with pH between 6.6 and 8.2 (McClure
et al., 2006). We found no evidence of pH-induced teratogenicity in
the literature; zebrafish can survive well in acidic water as low as pH
4.0 under laboratory conditions (Kwong et al., 2014). In addition, the ni-
trite levels measured along the IPR treatment are not likely to cause ter-
atogenic effects in zebrafish during embryogenesis (Simmons et al.,
2012; Keshari et al., 2016). Therefore, the physiochemical properties
of the IPR water (e.g. pH 6.0–8.5 and nitrite 0–3 mg/l) do not appear
to explain the teratogenic effects we saw. pH is an important determi-
nant of both solubility and partitioning of ionizable organic chemicals
in water. As pH decreased (from ~8.0 to ~6.0) along the treatment pro-
cess it may have influenced the exposure dynamics of zebrafish to cer-
tain chemicals in the water (Fig. 3).
4.3. Pathway level changes associated with IPR exposure
The biggest differences in global gene responses observed in any ex-
posure group (and between exposure groups) were caused by differ-
ences in developmental stage. By adjusting gene expression for
development, we found clear differences in global transcriptomic re-
sponses between embryos exposed to treatment water at either end
of the IPR process. These differences were also associated with de-
creases in the amount and concentration of chemicals in the water. To
illustrate, RO reduced the complexity and concentration of measured
chemicals in the treated water the most (Fig. S4 and Table S7), and
this was associated with a very pronounced change in global gene ex-
pression, and a complete absence of detected abnormalities in the fish
compared to the previous treatment stage. This suggests that RO is an
important and effective stage of IPR treatment in removing chemical
contaminants and their associated toxicological effects. However,
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(AOP2) significantly increased the incidence of teratogenic effects com-
pared to RO and aquarium control water, suggesting that unknown dis-
infection by-products (DBP)may be generated during the UV/H2O2 AOP
process. Indeed, we can infer that if sufficient monochloramine is pres-
ent in water post MF and/or RO, then DBP formation could occur in
AOP1 and AOP2, respectively (Wang et al., 2020). There were no signs
of altered expression of genes and pathways involved in oxidative stress
in embryos exposed to AOP waters, suggesting that reactive oxygen
species were unlikely to be responsible for the teratogenic effects
observed.
4.4. Pigmentation pathway responses
Having established that global gene expression was affected by ex-
posure to water at different treatment stages, we set out to identify
which genes and biological pathways had been altered, and to what ex-
tent these changes might account for the phenotypic abnormalities we
had observed. As pigmentation is normally visible from 24 hpf
(Kimmel et al., 1995), our discovery that some exposed embryos lacked
pigmentation (even after 48 h) was of interest. Changes to pigmenta-
tion in the exposed embryos appeared in the pathway analysis of global
gene expression as alterations to melanogenesis. Of the few genes that
were significantly differentially expressed, somatolactin-β (SLβ; a gly-
coprotein hormone that is exclusive to fish (Wan and Chan, 2010))
stood out because of its purported role in pigmentation (Fukamachi
et al., 2004, 2009; Zhu and Thomas, 1997; Nguyen et al., 2006). Signifi-
cant increases in transcription of the SLβ gene occurred in embryos ex-
posed to later treatment stages (i.e. RO, AOP2, FP and tap water),
whereas embryos visibly lacking pigmentation were seen at the early
stages of treatment (FE and after MF) and after advanced oxidation
(AOP2) (see Table 1). Melanin Concentrating Hormone (MCH) is
known to play an important role in pigmentation in animals, and is re-
ported to have a direct inhibitory role on Somatolactin expression and
release by fish pituitary cells in vitro via binding to the MCH receptor
(Tanaka et al., 2009). Analysis of pigment mutants in medaka (with
unique defects in proliferation andmorphogenesis of certain skin chro-
matophores) revealed specificmutations in the somatolactin gene lead-
ing to abnormal proliferation and morphogenesis of leucophores and
xanthophores (neural crest-derived pigment cells) (Kimura et al.,
2014). Therefore, it is possible that the observed increases in SLβ gene
transcription may have been a compensatory (negative feedback) re-
sponse to the observed suppression of melanogenesis pathways in ex-
posed embryos.
4.5. Steroidogenic, neurotransmitter and retinoid pathway responses
In addition to changes in melanogenesis pathways, steroid hormone
biosynthesis, retinol metabolism and tryptophanmetabolismwere also
altered (Table 4). Indeed, two cytochrome P450 family 1 genes (Cyp1a
and Cyp1b1) were significantly over expressed during the first three
stages of the IPR treatment process (FE, MF and AOP1). Cyp1a expres-
sion is known to be induced by a wide variety of aryl hydrocarbon re-
ceptor agonists (Bräunig et al., 2015; Denison and Nagy, 2003; Hinger
et al., 2011) and has attracted increasing interest as a biomarker of pol-
lution due to its important role in the metabolism and elimination of
aquatic contaminants in biota (Hook et al., 2014). Changes in the ex-
pression of Cyp1a may be a common factor in these responses, being
an important contributor to the biotransformation ofmany endogenous
substances, including melatonin, retinol, and various steroids (Lu et al.,
2020). Certain heavy metals have also been reported to enhance basal
levels of Cyp1a1 expression through transcriptional and post-
translational modifications; an effect that is enhanced with co-
exposure to the AhR agonist TCDD (Korashy and El-Kadi, 2005).
Together these findings suggest that organic and inorganic chemicals
(including AhR agonists and metals) may act together to affect10endocrine, neuroendocrine and paracrine responses through changes
in Cyp1a expression.
Recent evidence links exposure to various EDCs (including
chemicals that behave as estrogen or androgen agonists and antago-
nists) with neuroendocrine and reproductive deficits in wildlife and in
humans. This is particularly apparent when exposures occur during foe-
tal and early postnatal development (Dickerson and Gore, 2007; Gore
et al., 2015, 2018). The phenotypic consequences of disruption to ste-
roid estrogens and androgensmay only become apparent during sexual
differentiation and the development of secondary sex characteristics
(Brion et al., 2004) and would not be apparent in the very early
zebrafish embryos.
Alterations to tryptophanmetabolism (see Table S6) in the first 24 h
of development stood out because of its association with the synthesis
of important brain neurotransmitters needed to control mood (Seroto-
nin - anxiety and depression) and circadian rhythms (melatonin –
wakefulness, sleep cycles and normal patterns of appetite). The fact
that the circadian rhythm was altered at 48 hpf (Table S6) is likely to
be a consequence of disruption to melatonin production. Disruptions
in circadian rhythms have been recently identified as an important
area of current and future research into metabolism disrupting
chemicals (Mimoto et al., 2017), and may be associated with exposure
to various xenobiotics, including estrogenic chemicals and aryl hydro-
carbon receptor agonists (Rhee et al., 2014).
In addition to their protective role, upregulation of the Cyp450 detox-
ification pathways may alter tissue concentrations of retinoids resulting
in hormone imbalances (Katalin and Dvorak, 2011). Retinoids behave as
powerful morphogens during development, and both enhanced and re-
pressed levels of retinoids in vertebrate tissues during development are
associated with embryotoxicity and/or teratogenicity (Novák et al.,
2008; Rolland, 2000) due to changes to patterns of cellular differentiation
orchestrated during embryogenesis (Ross et al., 2000; Samarut et al.,
2015; Niederreither and Dollé, 2008). We replicated these abnormalities,
either wholly or partially, by exposing developing zebrafish to a retinoic
acid (RA) receptor-α antagonist ER50891 thereby strengthening the asso-
ciation between cause and effect (Table 5). Inhibition of the RA receptor
was chosen to emulate the consequences of downstream metabolic
changes thatmight affect RA availability in tissues or possiblemodulation
at the receptor itself. Indeed, RA is important for normal heart and coro-
nary development (Keegan et al., 2005; Pan and Baker, 2007; Zile, 2010;
Wang et al., 2018) and skeletal development (Green et al., 2016), making
a plausible link between the observed cardiovascular and skeletal effects
and the alterations to retinoid metabolism highlighted. Moreover, reti-
noid compounds, used widely in skin-lightening products and for treat-
ment of psoriasis and acne (Orfanos et al., 1997), are known to affect
pigmentation in zebrafish embryos and in vivo mammalian studies
(Brannen et al., 2010).
4.6. Data gaps and uncertainties
Although we can only speculate about the agents and mechanisms
responsible, retinoid imbalances may occur following exposure to vari-
ous organic pollutants (Novák et al., 2008) (including some pesticides,
PCBs and TCDD) aswell asmetal contaminants (Defo et al., 2014). Inter-
estingly, we found that metalloids, transition metals and alkaline earth
metal concentrations measured in IPR water samples were associated
with retinolmetabolism gene expression pathways. Thismay be related
to Cyp1a activation bymetals and AhR agonists as described previously.
However, asmetals arewidely used in a variety of personal care product
(PCP) formulations (Borowska and Brzóska, 2015), we should be mind-
ful that this relationship could occur by association of metals with
chemicals that are not routinely measured in current monitoring ap-
proaches. Curiously, various components of the retinoid system play
pivotal roles in mechanistic pathways associated with current disease
trends in humans (such as falling fertility and rising obesity rates
(Griswold et al., 2012; Keller et al., 1993; Chandra et al., 2008; Swan
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tors alone (Heindel et al., 2017). Despite this, our knowledge of the
cause and consequences of real-world exposures to chemical assaults
that may unhinge the retinoid system is still very much in its infancy
(Inoue et al., 2010).
5. Conclusions
History cautions us about the need to acknowledge and respond
quickly to ignorance, as well as uncertainty and risk, when protecting
the environment and public health against potential new and emerging
threats (European Environment Agency, 2001, 2013). Our study high-
lights that, despite our best efforts to use advanced treatment regimes,
perturbagens are present in the water at sufficient quantities to cause
biological effects during early embryogenesis in zebrafish. Identification
of causative chemicals is challenging, as chemistry data for all compo-
nents of these highly complex mixtures is not available. However, we
show that with an intermediate molecular characterisation we can
highlight relevant chemical groups and their associated biological re-
sponse. In the context of environmental health our findings highlight
the need for further research on the safety of advancedwater treatment
processes, with an emphasis on the impacts of organic and inorganic
contaminants on the retinoid system.
Schematic of methodological approach and IPR process. Details of
physicochemical properties of exposure waters. Approach to assess-
ment of developmental stages and abnormalities. Illustration of abnor-
malities. Details (average expression, target ID, p values, log-odds
value) of changes to the expression of individual genes in zebrafish ex-
posed to IPR treatment waters. Minimum false discovery rate (FDR) for
the loess normalised dataset using the SAM time-course analysis for
gene and pathway levels. Up- and down-regulated pathways with the
five lowest FDRs using the quantile normalised dataset signed area ap-
proach (with link to full pathway enrichment analysis). Detailed anno-
tation of chemical analytical features and gene expression profiles.
Changes to pesticides, EDC/Pharmaceuticals and Organics along the
IPR treatment plant process. Chemical concentrations measured as
part of the routine analyses of the IPR Plant by TW for the three exper-
iments undertaken as part of this project. Summary data of abnormality
data following independent developmental exposures to known
chemicals. Supplementary data to this article can be found online at
https://doi.org/10.1016/j.scitotenv.2021.147981.
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